Literature DB >> 22345153

p53/HMGB1 complexes regulate autophagy and apoptosis.

Kristen M Livesey1, Rui Kang, Philip Vernon, William Buchser, Patricia Loughran, Simon C Watkins, Lin Zhang, James J Manfredi, Herbert J Zeh, Luyuan Li, Michael T Lotze, Daolin Tang.   

Abstract

The balance between apoptosis ("programmed cell death") and autophagy ("programmed cell survival") is important in tumor development and response to therapy. Here, we show that high mobility group box 1 (HMGB1) and p53 form a complex that regulates the balance between tumor cell death and survival. We show that knockout of p53 in HCT116 cells increases expression of cytosolic HMGB1 and induces autophagy. Conversely, knockout of HMGB1 in mouse embryonic fibroblasts increases p53 cytosolic localization and decreases autophagy. p53 is thus a negative regulator of the HMGB1/Beclin 1 complex, and HMGB1 promotes autophagy in the setting of diminished p53. HMGB1-mediated autophagy promotes tumor cell survival in the setting of p53-dependent processes. The HMGB1/p53 complex affects the cytoplasmic localization of the reciprocal binding partner, thereby regulating subsequent levels of autophagy and apoptosis. These insights provide a novel link between HMGB1 and p53 in the cross-regulation of apoptosis and autophagy in the setting of cell stress, providing insights into their reciprocal roles in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345153      PMCID: PMC3417120          DOI: 10.1158/0008-5472.CAN-11-2291

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

2.  High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.

Authors:  Michal Stros; Eva Muselíková-Polanská; Sárka Pospísilová; François Strauss
Journal:  Biochemistry       Date:  2004-06-08       Impact factor: 3.162

3.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

Review 4.  Death by design: apoptosis, necrosis and autophagy.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

5.  Tumor-cell death, autophagy, and immunity.

Authors:  Louis M Weiner; Michael T Lotze
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

6.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells.

Authors:  H Garrett R Thompson; Joseph W Harris; Barbara J Wold; Fritz Lin; James P Brody
Journal:  Oncogene       Date:  2003-04-17       Impact factor: 9.867

8.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription.

Authors:  Sourav Banerjee; Tapas K Kundu
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

Review 10.  Apoptosis - the p53 network.

Authors:  Susan Haupt; Michael Berger; Zehavit Goldberg; Ygal Haupt
Journal:  J Cell Sci       Date:  2003-10-15       Impact factor: 5.285

View more
  119 in total

Review 1.  Ménage à Trois in stress: DAMPs, redox and autophagy.

Authors:  Guanqiao Li; Daolin Tang; Michael T Lotze
Journal:  Semin Cancer Biol       Date:  2013-08-28       Impact factor: 15.707

Review 2.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 3.  Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling.

Authors:  Philip J Vernon; Daolin Tang
Journal:  Antioxid Redox Signal       Date:  2012-09-18       Impact factor: 8.401

Review 4.  Aging and uremia: Is there cellular and molecular crossover?

Authors:  William E White; Muhammad M Yaqoob; Steven M Harwood
Journal:  World J Nephrol       Date:  2015-02-06

Review 5.  The emergence of noncoding RNAs as Heracles in autophagy.

Authors:  Jian Zhang; Peiyuan Wang; Lin Wan; Shouping Xu; Da Pang
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

Review 6.  DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death.

Authors:  Qiuhong Zhang; Rui Kang; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Autophagy       Date:  2013-02-06       Impact factor: 16.016

Review 7.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

8.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

Review 9.  Potential role of High mobility group box 1 in hepatocellular carcinoma.

Authors:  Rong-Rong Zhou; Xu-Yuan Kuang; Yan Huang; Ning Li; Ming-Xiang Zou; Dao-Lin Tang; Xue-Gong Fan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

10.  High mobility group box 1 (HMGB1) phenotypic role revealed with stress.

Authors:  Daolin Tang; Rui Kang; Bennett Van Houten; Herbert J Zeh; Timothy R Billiar; Michael T Lotze
Journal:  Mol Med       Date:  2014-08-19       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.